Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pulse Biosciences CS (PLSE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 215,237
  • Shares Outstanding, K 14,330
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,520 K
  • 36-Month Beta 3.72
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 9.63

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.81 +53.09%
on 09/13/17
23.00 -34.70%
on 08/23/17
-7.19 (-32.37%)
since 08/22/17
3-Month
9.81 +53.09%
on 09/13/17
37.50 -59.95%
on 06/26/17
-17.98 (-54.48%)
since 06/22/17
52-Week
5.20 +188.85%
on 12/15/16
39.50 -61.97%
on 06/20/17
+8.72 (+138.41%)
since 09/22/16

Most Recent Stories

More News
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Pulse Biosciences, Inc.

Levi & Korsinsky announces it has commenced an investigation of Pulse Biosciences, Inc. ("Pulse" or the "Company") (NASDAQ:PLSE) concerning possible violations of federal securities laws....

PLSE : 15.02 (-7.63%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Pulse Biosciences, Inc. (PLSE)

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pulse Biosciences, Inc. ("Pulse" or the "Company") (Nasdaq: PLSE). Such investors...

PLSE : 15.02 (-7.63%)
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Pulse Biosciences, Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Pulse Biosciences, Inc. (NASDAQ: PLSE) resulting...

PLSE : 15.02 (-7.63%)
Pulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTx(TM) System

Pulse Biosciences, Inc. (Nasdaq:PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform, announced today...

PLSE : 15.02 (-7.63%)
The Big Deal About Stem Cell Therapies and Regenerative Medicine

LAS VEGAS, July 28, 2017 /PRNewswire/ --

CYTX : 0.39 (-4.88%)
PLSE : 15.02 (-7.63%)
ENDV : 0.0362 (+20.67%)
PSTI : 1.54 (-1.28%)
CAPR : 2.14 (+7.00%)
Pulse Biosciences Quarterly Investor and Analyst Conference Call

Pulse Biosciences, Inc. (Nasdaq: PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform today reports...

PLSE : 15.02 (-7.63%)
Investor Network: Pulse Biosciences, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / July 27, 2017 / Pulse Biosciences, Inc. (NASDAQ: PLSE) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, July 27, 2017 at 4:30 PM Eastern...

PLSE : 15.02 (-7.63%)
Congress Could Have Major Impact on Biotech Companies

LAS VEGAS, July 21, 2017 /PRNewswire/ --

OSUR : 21.74 (+0.60%)
FGEN : 51.35 (-2.93%)
ENDV : 0.0362 (+20.67%)
PLSE : 15.02 (-7.63%)
CAPR : 2.14 (+7.00%)
Congress Could Have Major Impact on Biotech Companies

LAS VEGAS, July 21, 2017 /PRNewswire/ --

OSUR : 21.74 (+0.60%)
FGEN : 51.35 (-2.93%)
PLSE : 15.02 (-7.63%)
ENDV : 0.0362 (+20.67%)
CAPR : 2.14 (+7.00%)
Pulse Biosciences to Host Quarterly Investor Conference Call on July 27, 2017

Pulse Biosciences, Inc., (Nasdaq: PLSE) a medical technology company developing a proprietary therapeutic tissue treatment platform based on Nano-Pulse Stimulation (NPS), will host its quarterly...

PLSE : 15.02 (-7.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications...

See More

Support & Resistance

2nd Resistance Point 17.09
1st Resistance Point 16.06
Last Price 15.02
1st Support Level 14.47
2nd Support Level 13.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.